These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13480674)

  • 1. Peripheral glucose utilization after intravenous glucagon loading.
    SCHWAMM HA
    Helv Paediatr Acta; 1957 Oct; 12(4):361-74. PubMed ID: 13480674
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intravenous glucose tolerance test in water buffalo.
    Liu JG; Pan CL; Liu YW; Sun WD; Zhao HJ; Liu YJ; He CH; Wang XL
    Res Vet Sci; 2004 Aug; 77(1):23-7. PubMed ID: 15120949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the gut-brain axis in the control of glucose homeostasis.
    Migrenne S; Marsollier N; Cruciani-Guglielmacci C; Magnan C
    Curr Opin Pharmacol; 2006 Dec; 6(6):592-7. PubMed ID: 16990049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of glucagon on glucose utilization by the isolated rat diaphragm].
    GASTALDI F; RIZZO SC
    Arch Sci Med (Torino); 1959 Jan; 107(1):11-4. PubMed ID: 13650943
    [No Abstract]   [Full Text] [Related]  

  • 10. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men.
    Rigalleau V; Beauvieux MC; Gallis JL; Gin H; Schneiter P; Tappy L
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1198-204. PubMed ID: 16390862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective induction of inducible nitric oxide synthase in pancreatic islet of rat after an intravenous glucose or intralipid challenge.
    Ekelund M; Qader SS; Jimenez-Feltstrom J; Salehi A
    Nutrition; 2006 Jun; 22(6):652-60. PubMed ID: 16635563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central effects of thyronamines on glucose metabolism in rats.
    Klieverik LP; Foppen E; Ackermans MT; Serlie MJ; Sauerwein HP; Scanlan TS; Grandy DK; Fliers E; Kalsbeek A
    J Endocrinol; 2009 Jun; 201(3):377-86. PubMed ID: 19273499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
    Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagon and peripheral utilization of carbohydrates. I. Variations of differential arteriovenous glycemia and pyruvic acid in blood after glucagon administration].
    BUTTURINI U; D'ANTUONO G; PASSERI M; COCCHERI S; PRETOLANI E
    Boll Soc Ital Biol Sper; 1958 Jan; 34(1):21-4. PubMed ID: 13522943
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I; Tudurí E; Ripoll C; Nadal A
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.